comparemela.com

Page 6 - U11248 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ADC Toxicities: The Price You Pay for Efficacy

FDA Approves Bosutinib for Children With CML

The agency approved the tyrosine kinase inhibitor for pediatric patients with chronic phase Ph+ chronic myelogenous leukemia that is newly diagnosed or resistant or intolerant to prior therapy.

vimarsana © 2020. All Rights Reserved.